Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Tumour Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03402477
What this trial is testing

"Watch and Wait" After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.

Who this might be right for
Rectal Cancer
Helse Stavanger HF 86
Testing effectiveness (Phase 2)Study completedNCT01949701
What this trial is testing

Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shiga University 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439201
What this trial is testing

Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+2 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Looking for participantsNCT03556228
What this trial is testing

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Who this might be right for
Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more
VM Oncology, LLC 242
Testing effectiveness (Phase 2)Looking for participantsNCT07494565
What this trial is testing

Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)CD5 Positive
Sun Yat-sen University 60
Testing effectiveness (Phase 2)UnknownNCT04467801
What this trial is testing

Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy

Who this might be right for
NSCLC Stage IVNSCLC Stage IIIB
Jun Zhang, MD, PhD 60
Early research (Phase 1)Ended earlyNCT05501912
What this trial is testing

ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorBRAF V600 Mutation
ABM Therapeutics Shanghai Company Limited 20
Not applicableStudy completedNCT03911219
What this trial is testing

Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy

Who this might be right for
Stage IV Non-small Cell Lung CancerExtensive-stage Small Cell Lung CancerAdvanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC
iOMEDICO AG 154
Testing effectiveness (Phase 2)Study completedNCT01100931
What this trial is testing

A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)

Who this might be right for
NSCLCSolid Tumors
National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00996957
What this trial is testing

Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma

Who this might be right for
Advanced Solid TumorsMultiple Myeloma
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 37
Testing effectiveness (Phase 2)Looking for participantsNCT05323201
What this trial is testing

Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
The Affiliated Hospital of Xuzhou Medical University 15
Early research (Phase 1)Ended earlyNCT02138812
What this trial is testing

Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel

Who this might be right for
Medical Oncology
Bayer 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT04278781
What this trial is testing

AG-120 in People With IDH1 Mutant Chondrosarcoma

Who this might be right for
ChondrosarcomaChondrosarcoma, Grade 2Chondrosarcoma, Grade 3+1 more
Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00719836
What this trial is testing

SB1518 for the Treatment of Advanced Myeloid Malignancies

Who this might be right for
Acute Myelogenous LeukemiaChronic Myelogenous LeukemiaChronic Myelomonocytic Leukemia+2 more
S*BIO 76
Testing effectiveness (Phase 2)Ended earlyNCT02318901
What this trial is testing

Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer

Who this might be right for
Advanced CancerBreast CancerGastric Cancer+2 more
Western Regional Medical Center 16
Testing effectiveness (Phase 2)Ended earlyNCT00801801
What this trial is testing

Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC

Who this might be right for
Non Squamous Cell Lung CancerNon Small Cell Lung Cancer
Francisco Robert,MD 5
Testing effectiveness (Phase 2)Study completedNCT00146601
What this trial is testing

Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 35
Early research (Phase 1)Looking for participantsNCT07559019
What this trial is testing

Safety and Preliminary Activity of BI115 in Advanced SCLC

Who this might be right for
Small Cell Lung Cancer (SCLC)
Innovent Biologics (Suzhou) Co. Ltd. 150
Testing effectiveness (Phase 2)Study completedNCT00693719
What this trial is testing

Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of Arizona 31
Post-approval studies (Phase 4)Looking for participantsNCT05216328
What this trial is testing

Prevention of Opioid-induced Constipation in Patients With Advanced Cancer

Who this might be right for
Constipation, Opioid-Induced
Amsterdam UMC, location VUmc 330
Next Page